These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 4122812

  • 1. A guinea pig model for tumor immunology. A summary.
    Rapp HJ.
    Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
    [No Abstract] [Full Text] [Related]

  • 2. In vivo methods for the assessment of cell-mediated tumor immunity.
    Bartlett GL.
    Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z, Skotnicki AB.
    Przegl Lek; 1975 Dec; 32(5):460-5. PubMed ID: 50612
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ, Vogel CL, Ziegler JL, Kiryabwire JW.
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract] [Full Text] [Related]

  • 8. Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.
    Paque RE, Meltzer MS, Zbar B, Rapp HJ, Dray S.
    Cancer Res; 1973 Dec; 33(12):3165-71. PubMed ID: 4357351
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Application of transfer factor to clinical immunotherapy.
    Greco RS.
    Surg Gynecol Obstet; 1976 May; 142(5):765-78. PubMed ID: 772850
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.
    Zbar B, Bernstein ID, Rapp HJ.
    J Natl Cancer Inst; 1971 Apr; 46(4):831-9. PubMed ID: 4324814
    [No Abstract] [Full Text] [Related]

  • 15. [The immunology of cancer].
    Tabbara WS.
    J Med Liban; 1971 Apr; 24(3):209-26. PubMed ID: 5151404
    [No Abstract] [Full Text] [Related]

  • 16. [Immunology and cancer].
    Brunner KT.
    Schweiz Med Wochenschr; 1973 Sep 08; 103(36):1249-52. PubMed ID: 4584090
    [No Abstract] [Full Text] [Related]

  • 17. BCG in cancer therapy: theoretical bases of immunotherapy.
    Dodd MJ.
    Am J Nurs; 1979 Feb 08; 79(2):310-4. PubMed ID: 311587
    [No Abstract] [Full Text] [Related]

  • 18. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T.
    Kekkaku; 1980 Aug 08; 55(8):351-7. PubMed ID: 6999202
    [No Abstract] [Full Text] [Related]

  • 19. Letter: B.C.G. and immunological anergy.
    Lamoureux G, Poisson R.
    Lancet; 1974 May 18; 1(7864):989-90. PubMed ID: 4133674
    [No Abstract] [Full Text] [Related]

  • 20. Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.
    Snodgrass MJ, Hanna MG.
    Cancer Res; 1973 Apr 18; 33(4):701-16. PubMed ID: 4348772
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.